{"disease":{"id":"secondary-hemophagocytic-lymphohistiocytosis","name":"secondary hemophagocytic lymphohistiocytosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06339177","title":"Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05841342","title":"Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":128,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT05001737","title":"Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT05384743","title":"Rituximab Monotherapy for EBV-HLH and CAEBV","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT07531069","title":"Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Fudan University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}